Algert Global LLC Neogenomics Inc Transaction History

Algert Global LLC

$3.72 Billion
Q3 2024

A detailed history of Algert Global LLC transactions in Neogenomics Inc stock. As of the latest transaction made, Algert Global LLC holds 79,983 shares of NEO stock, worth $1.35 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

79,983

Previous 26,283 204.31%

Holding current value

$1.35 Million

Previous $365,000 223.29%

% of portfolio

0.03%

Previous 0.01%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$13.4 - $17.73 $719,580 - $952,101	53,700 Added 204.31%	79,983 $1.18 Million
Q2 2024 Aug 14, 2024	BUY	$13.01 - $15.77 $167,087 - $202,534	12,843 Added 95.56%	26,283 $365,000
Q3 2023 Nov 13, 2023	SELL	$12.15 - $17.85 $234,968 - $345,201	-19,339 Reduced 59.0%	13,440 $165,000
Q2 2023 Aug 14, 2023	SELL	$14.1 - $19.83 $1.12 Million - $1.57 Million	-79,103 Reduced 70.7%	32,779 $527,000
Q1 2023 May 12, 2023	SELL	$9.09 - $19.45 $911,663 - $1.95 Million	-100,293 Reduced 47.27%	111,882 $1.95 Million
Q4 2022 Feb 13, 2023	BUY	$6.45 - $12.07 $766,537 - $1.43 Million	118,843 Added 127.33%	212,175 $1.96 Million
Q3 2022 Nov 15, 2022	BUY	$7.86 - $12.91 $62,031 - $101,885	7,892 Added 9.24%	93,332 $804,000
Q2 2022 Aug 15, 2022	BUY	$7.06 - $13.97 $603,206 - $1.19 Million	85,440 New	85,440 $696,000
Q4 2021 Feb 14, 2022	SELL	$30.49 - $48.49 $240,627 - $382,683	-7,892 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$41.66 - $52.52 $328,780 - $414,487	7,892 New	7,892 $381,000
Q2 2021 Aug 13, 2021	SELL	$36.62 - $51.69 $459,251 - $648,244	-12,541 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$41.56 - $59.88 $521,203 - $750,955	12,541 New	12,541 $605,000

Others Institutions Holding NEO

# of Institutions

295

Shares Held

125M

Call Options Held

698K

Put Options Held

120K

View Full List

About NEOGENOMICS INC

Ticker NEO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 125,796,000
Market Cap $2.13B
Description
NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...

More about NEO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Algert Global LLC, based on Form 13F filings with the SEC.

News

Stay updated on Algert Global LLC with notifications on news.

Account

Algert Global LLC Neogenomics Inc Transaction History